Clinical Trials
5 trialsNCT07043608 2026-05-01
ZAMBONI
University of California, San Francisco
Phase 2 Not yet recruiting
NCT00987636 2019-10-22
EWING2008
University Hospital Muenster
Phase 3 Completed
NCT03811509 2019-01-28
B-ABLE
Parc de Salut Mar
Phase 4 Unknown
NCT01215344 2018-05-15
First Autologous Transplant on Minimal Residual Disease Markers in Previously Untreated Myeloma Undergoing Initial Treatment With Velcade
Vanderbilt-Ingram Cancer Center
Phase 2 Completed
NCT00222053 2010-04-02
IFM 99-02 Thalidomide in Myeloma
University Hospital, Toulouse
Phase 3 Completed